Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nephrotic Syndrome and Hodgkins Lymphoma - an Unusual Association. | EJIFCC | 2022 | 36447800 | PubTator, text mining | PubMed |
| Lymphoepithelioma-Like Carcinoma of the Lung Associated With Epstein-Barr Virus in a Caucasian Patient: A Case Report. | Cureus | 2022 | 36447682 | PubTator, text mining | PubMed |
Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein-Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis. | Asian Pac J Cancer Prev | 2022 | 36444584 | PubTator, text mining | PubMed |
| Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. | Infect Agent Cancer | 2022 | 36437456 | PubTator, text mining | PubMed |
| Cholesterol metabolism and lipid droplet vacuoles; a potential target for the therapy of aggressive lymphoma. | J Clin Exp Hematop | 2022 | 36436934 | PubTator, text mining | PubMed |
| Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses. | Int J Mol Sci | 2022 | 36430369 | PubTator, text mining | PubMed |
| Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma. | Cancers (Basel) | 2022 | 36428710 | PubTator, text mining | PubMed |
| The Impact of Deleting Stem-Loop 1 of Epstein-Barr Virus-Encoded RNA 1 on Cell Proliferation. | Viruses | 2022 | 36423146 | PubTator, text mining | PubMed |
| Application of extracellular vesicles proteins in cancer diagnosis. | Front Cell Dev Biol | 2022 | 36407096 | PubTator, text mining | PubMed |
| Low Level of Advanced Glycation End Products in Serum of Patients with Allergic Rhinitis and Chronic Epstein-Barr Virus Infection at Different Stages of Virus Persistence. | J Immunol Res | 2022 | 36405008 | PubTator, text mining | PubMed |
| The prognostic value of Epstein-Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis. | Front Oncol | 2022 | 36387159 | PubTator, text mining | PubMed |
| Gender-related differentially expressed genes in pancreatic cancer: possible culprits or accomplices? | Front Genet | 2022 | 36386839 | PubTator, text mining | PubMed |
| Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. | Biochem J | 2022 | 36383217 | PubTator, text mining | PubMed |
| Phenotype and genotype in a Taiwanese girl with Sotos Syndrome. | Biomedicine (Taipei) | 2022 | 36381192 | PubTator, text mining | PubMed |
| Recent advances on small molecules in osteogenic differentiation of stem cells and the underlying signaling pathways. | Stem Cell Res Ther | 2022 | 36371202 | PubTator, text mining | PubMed |
| Buffy Coat Transcriptomic Analysis Reveals Alterations in Host Cell Protein Synthesis and Cell Cycle in Severe COVID-19 Patients. | Int J Mol Sci | 2022 | 36362378 | PubTator, text mining | PubMed |
| Reprograming of Gene Expression of Key Inflammatory Signaling Pathways in Human Peripheral Blood Mononuclear Cells by Soybean Lectin and Resveratrol. | Int J Mol Sci | 2022 | 36361735 | PubTator, text mining | PubMed |
| Effects of Composition and Strength of Wheat Gluten on Starch Structure, Digestion Properties and the Underlying Mechanism. | Foods | 2022 | 36360045 | PubTator, text mining | PubMed |
| HPV-Related Cervical Cancer and Extracellular Vesicles. | Diagnostics (Basel) | 2022 | 36359429 | PubTator, text mining | PubMed |
| Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting. | Biomedicines | 2022 | 36359340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=24